Page 2 - Daniel Blumenthal News Today

For seven decades, China’s Communist Party has ruled the world’s most populous country. As the country’s population crests and begins to shrink, experts say, it will face challenges ranging from supporting the elderly to filling the ranks of its military. Population growth has been slowing for years, but the announcement Tuesday that the country’s population fell by about 850,000 in 2022 came sooner than expected. “Those developments... may well feed domestic challenges at home and str...

BEIJING (AP) -- For seven decades, China's Communist Party has ruled the world's most populous country. As the nation's population crests and begins to

For seven decades, China’s Communist Party has ruled the world’s most populous country

As China's population begins to shrink, it will face challenges ranging from supporting the elderly to filling the ranks of its military, experts say.

For seven decades, China’s Communist Party has ruled the world’s most populous country. As the nation’s population crests and begins to shrink, experts

<div class="at-above-post addthis_tool" data-url="http://www.metro.us/threats-advantages-in-shrinking-population/"></div>BEIJING (AP) — For seven decades, China’s Communist Party has ruled the world’s most populous country. As the nation’s population crests and begins to shrink, experts say, it will face challenges ranging from supporting the elderly to filling the ranks of its military. Population growth has been slowing for years, but the ann...

Threats, advantages seen in Chinas shrinking population

House Speaker Nancy Pelosi’s plans to travel to Taiwan has created a stir in both Beijing and Washington. Susan Shirk, chair of the 21st Century China Center at UC San Diego and a former member of the Clinton administration, and Daniel Blumenthal, a fellow at the American Enterprise Institute and a former senior director in the Defense Department under George W. Bush, join Amna Nawaz to discuss.

In both China and the U.S., the Ukraine conflict is shifting strategic thinking on Taiwan. All sides face high stakes.

/PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies,...